0001396677-11-000035.txt : 20110927 0001396677-11-000035.hdr.sgml : 20110927 20110927180934 ACCESSION NUMBER: 0001396677-11-000035 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20110927 FILED AS OF DATE: 20110927 DATE AS OF CHANGE: 20110927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GAY FRANK W II CENTRAL INDEX KEY: 0001079725 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 111110479 MAIL ADDRESS: STREET 1: NUTRACETICAL INTERNATIONAL CORP STREET 2: 1400 KEARNS BLVD 2ND FL. CITY: PARK CITY STATE: UT ZIP: 84060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0304 4/A 2011-09-27 2011-09-27 0 0001050007 NUTRACEUTICAL INTERNATIONAL CORP NUTR 0001079725 GAY FRANK W II NUTRACETICAL INTERNATIONAL CORP 1400 KEARNS BLVD 2ND FL. PARK CITY UT 84060 1 1 0 0 Chairman & CEO Common Stock 2010-12-14 5 G 0 E 13000 0 D 727899 D Common Stock 2011-09-23 4 M 0 5000 3.5 A 732899 D Common Stock 2011-09-23 4 S 0 5000 13.2388 D 727899 D Common Stock 2011-09-26 4 M 0 7000 3.5 A 734899 D Common Stock 2011-09-26 4 S 0 7000 13.24 D 727899 D Common Stock 2011-09-27 4 M 0 5900 3.5 A 733799 D Common Stock 2011-09-27 4 S 0 5900 13.468 D 727899 D Employee Stock Option (right to buy) 3.5 2011-09-23 4 M 0 5000 0 D 2011-12-13 Common Stock 5000 70000 D Employee Stock Option (right to buy) 3.5 2011-09-26 4 M 0 7000 0 D 2011-12-13 Common Stock 7000 63000 D Employee Stock Option (right to buy) 3.5 2011-09-27 4 M 0 5900 0 D 2011-12-13 Common Stock 5900 57100 D Exercise of options expiring on December 13, 2011. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 22, 2011. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.12 to $13.31. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price shown in this Column 4 is a weighted average sale price. The price range for the sales is $13.15 to $13.30. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The price shown in Column 4 is a weighted average sale price. The price range for the sales is $13.31 to $13.60. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. The option vested in six equal installments beginning on June 13, 2002. /s/ Alison Pitt, attorney in fact 2011-09-27